Frontlight ResearchEarly access
Atrial fibrillation trials in Israel
3 of 5 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleSex-Based Disparities in the Electrophysiological Substrate for Atrial Fibrillation and Its Impact on Clinical Outcomes
- Where
- Be’er Ya‘aqov
- Age
- 18 years to 80 years
- People
- 100
- Run by
- Anat Milman
See details and how to joinNCT07580547 - Phase 3Taking peopleStudy to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
- Where
- Afula, Ashkelon, Beersheba, Hadera, Haifa, Holon, Jerusalem, Kfar Saba, Nahariya, Petah Tikva, Rehovot, Safed
- Age
- 65 years and over
- People
- 2,500 worldwide
- Run by
- Anthos Therapeutics, Inc.
See details and how to joinNCT05712200 · EU 2023-503224-66-00 - No phaseTaking peopleComparative Evaluation of Optrell and Octaray Mapping Catheters for Conduction Block Confirmation and Voltage Assessment During Atrial Ablation
- Where
- Be’er Ya‘aqov
- Age
- 18 years and over
- People
- 30
- Run by
- Maxime Zabern
See details and how to joinNCT07563257